Report cover image

Global Biopharmaceutical Process Analytical Technology Market Size Study, by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), End User, and Regional Forecasts 202

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20379274

Description

The Global Biopharmaceutical Process Analytical Technology Market, valued at approximately USD 1.1 billion in 2024, is projected to grow at an impressive compound annual growth rate (CAGR) of 16.40% over the forecast period 2024-2034. This robust growth trajectory is fueled by increasing adoption of advanced analytical technologies to enhance process efficiency, quality assurance, and regulatory compliance in biopharmaceutical manufacturing. Technologies such as Liquid Chromatography (LC), Gas Chromatography (GC), and Next-Generation Sequencing (NGS) are paving the way for unprecedented accuracy and precision in bioprocessing.

The rising demand for biologics and vaccines, compounded by global health challenges, has significantly heightened the need for process analytical technologies. The industry is experiencing a surge in the adoption of sensors and software solutions that allow real-time monitoring and control, ensuring consistency and reducing production cycle times. While innovations like Raman and Infrared (IR) Spectroscopy enhance analytical capabilities, the high costs of equipment and expertise may pose challenges in widespread implementation, especially in emerging markets.

North America dominates the global market, leveraging its established biopharmaceutical infrastructure, significant R&D investments, and stringent regulatory landscape. Europe follows closely, supported by a strong focus on innovation and healthcare advancements. Meanwhile, the Asia-Pacific region is expected to emerge as the fastest-growing market, driven by rising pharmaceutical production, expanding biotechnology ventures, and increasing government funding in countries like China and India. Latin America and the Middle East & Africa are also witnessing gradual adoption of these technologies, as stakeholders invest in improving healthcare and manufacturing capacities.

Major Market Players Included in This Report Are:
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific
  • PerkinElmer, Inc.
  • Danaher Corporation
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Shimadzu Corporation
  • Bruker Corporation
  • Merck KGaA
  • Sartorius AG
  • Mettler Toledo
  • JEOL Ltd.
  • Horiba, Ltd.
  • Metrohm AG
  • Tecan Group Ltd.
The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Technology:
  • Liquid Chromatography (LC)
  • Gas Chromatography (GC)
  • Mass Spectrometry (MS)
  • Quantitative PCR (qPCR)
  • Next-Generation Sequencing (NGS)
  • Nuclear Magnetic Resonance (NMR)
  • Raman Spectroscopy
  • Infrared (IR) Spectroscopy
By Product:
  • Analyzer
  • Sensor
  • Software
By Application:
  • Vaccine
  • Biologics
  • Cell and Gene Therapy (CGT)
By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Contract Manufacturing Organizations (CMOs)
By Region:

North America:
  • U.S.
  • Canada
Europe:
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America
Middle East & Africa:
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years Considered for the Study Are as Follows:
  • Historical Year: 2022
  • Base Year: 2024
  • Forecast Period: 2024 to 2034
Key Takeaways:
  • Market estimates and forecasts spanning a decade.
  • Regional and country-level insights, emphasizing emerging growth hubs.
  • In-depth competitive analysis featuring major players and strategic initiatives.
  • Analysis of market dynamics, including drivers, challenges, and opportunities.
  • Actionable recommendations for stakeholders to optimize investments and growth strategies.

Table of Contents

285 Pages
Chapter 1. Global Biopharmaceutical Process Analytical Technology Market Executive Summary
1.1. Global Biopharmaceutical Process Analytical Technology Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Technology
1.3.2. By Product
1.3.3. By Application
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
________________________________________
Chapter 2. Global Biopharmaceutical Process Analytical Technology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
________________________________________
Chapter 3. Global Biopharmaceutical Process Analytical Technology Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Adoption of Advanced Analytical Technologies
3.1.2. Rising Demand for Biologics and Vaccines
3.1.3. Technological Advancements in Process Monitoring
3.2. Market Challenges
3.2.1. High Costs of Equipment and Implementation
3.2.2. Requirement for Skilled Technical Personnel
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets of Asia-Pacific
3.3.2. Integration of Advanced Sampling Methods
3.3.3. Development of Healthcare and Industrial Infrastructure in Developing Regions
________________________________________
Chapter 4. Global Biopharmaceutical Process Analytical Technology Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.1.7. Porter’s Five Forces Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
________________________________________
Chapter 5. Global Biopharmaceutical Process Analytical Technology Market Size & Forecasts by Technology 2024-2034
5.1. Segment Dashboard
5.2. Global Biopharmaceutical Process Analytical Technology Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Liquid Chromatography (LC)
5.2.2. Gas Chromatography (GC)
5.2.3. Mass Spectrometry (MS)
5.2.4. Quantitative PCR (qPCR)
5.2.5. Next-Generation Sequencing (NGS)
5.2.6. Nuclear Magnetic Resonance (NMR)
5.2.7. Raman Spectroscopy
5.2.8. Infrared (IR) Spectroscopy
________________________________________
Chapter 6. Global Biopharmaceutical Process Analytical Technology Market Size & Forecasts by Product 2024-2034
6.1. Segment Dashboard
6.2. Global Biopharmaceutical Process Analytical Technology Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Analyzer
6.2.2. Sensor
6.2.3. Software
________________________________________
Chapter 7. Global Biopharmaceutical Process Analytical Technology Market Size & Forecasts by Application 2024-2034
7.1. Segment Dashboard
7.2. Global Biopharmaceutical Process Analytical Technology Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Vaccine
7.2.2. Biologics
7.2.3. Cell and Gene Therapy (CGT)
________________________________________
Chapter 8. Global Biopharmaceutical Process Analytical Technology Market Size & Forecasts by End User 2024-2034
8.1. Segment Dashboard
8.2. Global Biopharmaceutical Process Analytical Technology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Biotechnology and Pharmaceutical Companies
8.2.2. Academic and Research Institutes
8.2.3. Contract Manufacturing Organizations (CMOs)
________________________________________
Chapter 9. Global Biopharmaceutical Process Analytical Technology Market Size & Forecasts by Region 2024-2034
9.1. North America Biopharmaceutical Process Analytical Technology Market
9.1.1. U.S. Biopharmaceutical Process Analytical Technology Market
9.1.1.1. Technology Breakdown Size & Forecasts, 2024-2034
9.1.1.2. Sampling Method Breakdown Size & Forecasts, 2024-2034
9.1.1.3. Component Breakdown Size & Forecasts, 2024-2034
9.1.1.4. End User Breakdown Size & Forecasts, 2024-2034
9.1.1.5. Application Breakdown Size & Forecasts, 2024-2034
9.1.2. Canada Biopharmaceutical Process Analytical Technology Market
9.1.2.1. Technology Breakdown Size & Forecasts, 2024-2034
9.1.2.2. Sampling Method Breakdown Size & Forecasts, 2024-2034
9.1.2.3. Component Breakdown Size & Forecasts, 2024-2034
9.1.2.4. End User Breakdown Size & Forecasts, 2024-2034
9.1.2.5. Application Breakdown Size & Forecasts, 2024-2034
________________________________________
9.2. Europe Biopharmaceutical Process Analytical Technology Market
9.2.1. UK Biopharmaceutical Process Analytical Technology Market
9.2.2. Germany Biopharmaceutical Process Analytical Technology Market
9.2.3. France Biopharmaceutical Process Analytical Technology Market
9.2.4. Spain Biopharmaceutical Process Analytical Technology Market
9.2.5. Italy Biopharmaceutical Process Analytical Technology Market
9.2.6. Rest of Europe Biopharmaceutical Process Analytical Technology Market
________________________________________
9.3. Asia-Pacific Biopharmaceutical Process Analytical Technology Market
9.3.1. China Biopharmaceutical Process Analytical Technology Market
9.3.2. India Biopharmaceutical Process Analytical Technology Market
9.3.3. Japan Biopharmaceutical Process Analytical Technology Market
9.3.4. Australia Biopharmaceutical Process Analytical Technology Market
9.3.5. South Korea Biopharmaceutical Process Analytical Technology Market
9.3.6. Rest of Asia-Pacific Biopharmaceutical Process Analytical Technology Market
________________________________________
9.4. Latin America Biopharmaceutical Process Analytical Technology Market
9.4.1. Brazil Biopharmaceutical Process Analytical Technology Market
9.4.2. Mexico Biopharmaceutical Process Analytical Technology Market
9.4.3. Rest of Latin America Biopharmaceutical Process Analytical Technology Market
________________________________________
9.5. Middle East & Africa Biopharmaceutical Process Analytical Technology Market
9.5.1. Saudi Arabia Biopharmaceutical Process Analytical Technology Market
9.5.2. South Africa Biopharmaceutical Process Analytical Technology Market
9.5.3. Rest of Middle East & Africa Biopharmaceutical Process Analytical Technology Market
________________________________________
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Agilent Technologies, Inc.
10.1.2. Thermo Fisher Scientific
10.1.3. PerkinElmer, Inc.
________________________________________
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Agilent Technologies, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Thermo Fisher Scientific
10.3.3. PerkinElmer, Inc.
10.3.4. Danaher Corporation
10.3.5. Waters Corporation
10.3.6. Bio-Rad Laboratories, Inc.
10.3.7. Shimadzu Corporation
10.3.8. Bruker Corporation
10.3.9. Merck KGaA
10.3.10. Sartorius AG
10.3.11. Mettler Toledo
10.3.12. JEOL Ltd.
10.3.13. Horiba, Ltd.
10.3.14. Metrohm AG
10.3.15. Tecan Group Ltd.
________________________________________
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us